Showing results (61-70 of 588) with videos related to

Sort By:
Pageof 59
Cancer Research|July 19, 2002
A hereditary nonpolyposis colorectal carcinoma case associated with hypermethylation of the MLH1 gene in normal tissue and loss of heterozygosity of the unmethylated allele in the resulting microsatellite instability-high tumorIsabella Gazzoli, Massimo Loda, Judy Garber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2009
Risk of bilateral renal cell cancerFredrik Wiklund, Steinar Tretli, Toni K Choueiri, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 27, 2013
p63-expressing cells are the stem cells of developing prostate, bladder, and colorectal epitheliaJean-Christophe Pignon, Chiara Grisanzio, Yan Geng, et al.
International Journal of Colorectal Disease|November 25, 2003
Humoral immune response to p53 correlates with clinical course in colorectal cancer patients during adjuvant chemotherapyMirna Lechpammer, Josip Lukac, Stanislav Lechpammer, et al.
The Journal of Molecular Diagnostics : JMD|October 27, 2006
CpG island methylator phenotype-low (CIMP-low) in colorectal cancer: possible associations with male sex and KRAS mutationsShuji Ogino, Takako Kawasaki, Gregory J Kirkner, et al.
Plos One|December 14, 2012
A synthetic form of frizzled 8-associated antiproliferative factor enhances p53 stability through USP2a and MDM2Jayoung Kim, Susan K Keay, Sungyong You, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 22, 2010
The metabolic syndrome and the risk of prostate cancer under competing risks of death from other causesBirgitta Grundmark, Hans Garmo, Massimo Loda, et al.
Molecular and Cellular Biology|November 16, 2004
Genetic interaction between Rb and K-ras in the control of differentiation and tumor suppressionChiaki Takahashi, Bernardo Contreras, Roderick T Bronson, et al.
Journal of Cancer Epidemiology|February 13, 2013
Serum lipid profiles and cancer risk in the context of obesity: four meta-analysesJennifer C Melvin, Lars Holmberg, Sabine Rohrmann, et al.
Cell Cycle (Georgetown, Tex.)|February 29, 2012
The ubiquitin-specific protease USP2a enhances tumor progression by targeting cyclin A1 in bladder cancerJayoung Kim, Wun-Jae Kim, Zhiqian Liu, et al.
Pageof 59